Rhythm Pharmaceuticals (RYTM) Exchange Rate Effect (2023 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Exchange Rate Effect of $448000.0 for Q1 2026, up 22500.0% year-over-year from N/an in Q1 2025, and up 600.0% quarter-over-quarter from $64000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 4 years of Exchange Rate Effect data on file, last reported at $448000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $448000.0, up 22500.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $537000.0 (up 656.34% YoY), and the FY2025 annual result was $87000.0, up 4250.0% from the prior year.
- Exchange Rate Effect grew to $448000.0 in Q1 2026 per RYTM's latest filing, from $64000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $977000.0 in Q4 2024 and troughed at -$603000.0 in Q3 2024.
- A 4-year average of $30384.6 and a median of -$2000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2024 and 2026: Exchange Rate Effect tumbled 883.12% in 2024, then jumped 22500.0% in 2026.
- A 4-year view of Exchange Rate Effect shows it stood at -$192000.0 in 2023, then surged by 608.85% to $977000.0 in 2024, then slumped by 93.45% to $64000.0 in 2025, then jumped by 600.0% to $448000.0 in 2026.
- Business Quant data shows RYTM's Exchange Rate Effect at $448000.0 in Q1 2026, $64000.0 in Q4 2025, and $304000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Rhythm Pharmaceuticals | 6.59 Bn | 6.25 Bn | 52.96 Mn | 448,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 448,000.00 |
| Mar 31, 2026 | 448,000.00 |
| Dec 31, 2025 | 64,000.00 |
| Dec 31, 2025 | 64,000.00 |
| Sep 30, 2025 | 304,000.00 |
| Sep 30, 2025 | 304,000.00 |
| Jun 30, 2025 | -279,000.00 |
| Jun 30, 2025 | -279,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Dec 31, 2024 | 977,000.00 |
| Dec 31, 2024 | 977,000.00 |
| Sep 30, 2024 | -603,000.00 |
| Sep 30, 2024 | -603,000.00 |
| Jun 30, 2024 | -301,000.00 |
| Jun 30, 2024 | -301,000.00 |
| Mar 31, 2024 | -71,000.00 |
| Mar 31, 2024 | -71,000.00 |
| Dec 31, 2023 | -192,000.00 |
| Dec 31, 2023 | -192,000.00 |